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Materials and Methods: The test is performed with a cubic 
phantom (Penta-Guide) with air-filled spheres and dedicated 
to CBCT quality assurance. The HexaPODTM table is positioned 
in its zero location to allow maximum corrections in all 
directions. The Penta-Guide is located at the isocentre with 
the room lasers and we apply known displacements in all 
translational directions with the phantom off-centre cross 
hair (10 mm X, 14 mm Y and 12 mm Z). Positioning accuracy 
is tested by comparing a reference CBCT phantom image with 
the weekly CBCT by the grey scale auto match tools of Elekta 
XVI. The translational and rotational corrections determined 
by registration are then transferred to the iGuide system, the 
software that controls de HexaPODTM table, to apply the 
requested shifts to reposition the phantom. Translational and 
rotational position errors are recorded and analyzed. 
Results: From 25 images (which correspond to 75 
translational and 75 rotational displacement measurements), 
we have found that 97.3% of all translational errors in 
achieving the isocentre location are <=1 mm (96% in 
longitudinal and vertical directions and 100% in lateral 
direction). The average translational error is 0.47 mm 
longitudinal (0.20 – 1.40 mm), 0.45 mm lateral (0.00 – 1.00 
mm) and 0.34 mm vertical (0.00 – 1.10 mm). 92% of all 
rotational errors are <=0.3º (88% roll, 92% pitch and 96% 
yaw). The average rotational error is 0.15º roll (0.00º – 
0.40º), 0.17º pitch (0.00º – 0.40º) and 0.13º yaw (0.00º – 
0.50º). 
Conclusions: The HexaPODTM table can correct setup errors in 
all planes with a very high precision level. A QA procedure is 
necessary to detect errors in a system with a sub-millimetre 
and a sub-degree accuracy aim. This QA test assures that 
mean setup error do not exceed 0.5 mm in translational 
directions and is below 0.2º in rotational movements. If we 
find errors exceeding our action levels (2 mm in translational 
and 1º rotational), further investigations have to be done. 
Because its simplicity and the benefits that can report to 
patient setup, we are considering to implement this test in 
our clinical daily basis. 
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Purpose/Objective: to evaluate the efficacy of the Image 
Guided Radiotherapy (IGRT) with daily Megavoltage CT 
(MVCT) and acute toxicity in patients with nasopharynx 
cancer treated with HT. 
Materials and Methods: From January 2013 to May 2014, 13 
patients (pts), 9 females and 4 males, median age 64 years, 
with nasopharynx cancer (T2-T4a N2-N3), were treated and 
evaluate for acute toxicity, analyzing loss of weight, 
xerostomia, dysphagia, mucositis and dermatitis. Among 
them, 9 pts underwent platinum-based chemotherapy and 
concomitant radiotherapy and 4 pts exclusive radiotherapy, 3 
due to poor general condition and 1 for the elderly. Three 
differents planning target volume (PTVs) were defined: PTV1 
included nasopharynx (local disease and margin) to a total 
dose (DT) of 69.96 Gy in 33 fractions (frs) with a daily fr of 
2.12 Gy; PTV2 included lymph nodes high risk and we 
administered a DT of 59.4Gy in 33 frs at a daily fr of 1.8 Gy. 
PTV3 included lymph nodes low risk treated with a DT of 
54.12 Gy in 33 frs at a daily fr of 1.64 Gy. Acute toxicity was 
evaluated using a questionnaire NCI- CTCAE 4.0 modified by a 
subjective scale of values from 1 to 10 (1 at the worst result 
and 10 at the best) investigating different types of toxicity in 
particular: xerostomia, dysphagia for liquids and solids (L/S), 
dysgeusia. We evaluate also weight loss and, according to the 
RTOG toxicity scales, skin toxicity and mucositis. Daily MVCT 
was performed in each patient. 
Results: The median weight loss in the mid-treatment (mt) 
was 1,7 Kg, to the end of radiotherapy (ft) of 2.8 kg, to the 
first follow-up (1FU) of 3.2 kg, to the second FU (2FU) of 1.2 
kg. The evaluation of xerostomia has detected a score of 6.2 
to the mt and 5.3 to the ft, of 6.4 to the 1FU and 5.8 to the 
2FU. Dysphagia (L/S) was evaluated to the mt of 5/5, 4.7/3.7 
to the ft, 6.5/6.2 to the 1FU while 8/7.7 to the 2FU. 
Dysgeusia was 6.1 to the mt, 4.5 to the ft, 4.7 to the 1FU and 
6,1 to the 2FU. Mucositis was mild to severe G1-G3, 1 case 
has evolved into G4. Skin toxicity G1-G2. 3 patients were re-
simulate: two for loss of weight between second and the fifth 
week and the other patient at the first week for weight 
increased for concomitant use of steroids. In these cases, the 
MVCT occurred geographic miss with a hotspot on the bone 
marrow. IGRT allowed to record mismatching in 3 pts due to 
loss or increase of weight and re-simulate them. Dose 
constraints to organs at risk were easily respect in almost 
every patient due to high dose conformity allowed by HT, but 
correct contouring remains still critical. 22-24 Gy average 
planning dose was reported for parotid glands. 
Conclusions: Our experience suggest us the use of daily MVCT 
is very important in the Head & Neck cancer, to identify early 
both any changes in anatomy of patient due to an important 
weight loss, and an undersizing of the lesion in response to 
therapy, for a treatment as conformed and adapted to the 
structure of the single patient. The acute toxicity is 
acceptable. 
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Purpose/Objective: In November 2013, Radiation Oncology 
Victoria (ROV) underwent a change in its radiation therapist 
staffing model to become a smarter and more efficient 
service provider. This project was developed to assess and 
test the hypothesis that patient satisfaction and experience 
can be maintained at high levels after a change in staffing 
model, testing the belief that staffing numbers impact on 
quality of service as measured by satisfaction. By analysing 
survey data using a Net Promoter Score (NPS) methodology, 
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and benchmarking both internally and externally, an 
assessment and determination of satisfaction has been 
possible. 
Materials and Methods: The standard AIR staffing model 
(from 2001) which is routinely utilised in Australia states a 
requirement of 4.5 FTE on a Linear Accelerator treating 
around 40 patients per day. Following a workflow redesign, 
ROV implemented a staffing model of 3.0FTE for a similar 
workload on its Linear Accelerator fleet. After this change, 
patient satisfaction with the service was assessed by 
obtaining patient satisfaction scores using an iPad device 
connected to cloud based software using a net promoter 
score methodology. The recorded scores of satisfaction were 
compared to both internal and external controls and 
demonstrated that changes to the staffing model had no 
impact on the quality of service provided.  
Results: After 13 months of data collection involving 1688 
patients across 5 sites, the NPS data analysis demonstrates a 
consistent score of at least 70% (noting a NPS score of >40% is 
considered very good).  
Conclusions: The data demonstrates that the new staffing 
model adopted by ROV maintains excellent levels of service 
as evidenced by patient satisfaction. ROV continues to 
monitor patient satisfaction on an ongoing basis to ensure the 
service provided continues to meet or exceed expectations. 
In the event that a respondent is dissatisfied by a score on 
any metric of less than 60%, contact with the respondent is 
made immediately as the cloud based system provides real 
time notification to a manager. 
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Purpose/Objective: Comorbidity assessment is essential to 
triage of care for men with prostate cancer. Specially in 
these with an expectative of life less of ten yars.. We tried to 
make a Spanish validation of revised Charlson index (RCI) 
applied to prostate cancer. 
Materials and Methods: A group of 619 consecutive cases of 
prostate cancer diagnosed between 1994 to 2007 weresend 
for clinical assessment at radiation oncology department of 
hospital Clinic of Bacelona. A long the period of follow-up 69 
patients deceased for prostate cancer and were excluded in 
this study inorder to determine the risks of mortality 
associated with comorbidities measured by the RCI. RCI was 
classified in three categories 0 to 2 , 3 to 4 and 5 and higher. 
For this purpose we used Kaplan-Meier method and Cox 
proportional hazards modeling . 
Results: Finally 550 patients with prostate cancer were 
included, with median age of 70 years old (47-85), Mean 
follow-up time was 136.8 months, between 5,6 and 245,8 
months. D’Amico risk classification distribution was for low, 
mediun and high risk 20.4%, 36,5% and 43,1% respectively. 
RCI distribution categories was as follows 61,5%, 21,8 and 
16,7%. Survival analysis showed significant differences 
(p<0.001) between RCI groups at 5 and 10 years. Survival 
probability was 98,2 and 88,5% ; 95% and 79,6% ; and 52,2% 
and 8,9% respectively for each RCI category.  
Conclusions: RCI allowed for more accurate identification of 
men at highest risk for other cause mortality. Our results are 
in concordance with original RCI .This revised index may be 
used to aid medical decision making for men with prostate 
cancer. 
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Purpose/Objective: Short-course radiotherapy (SCRT) 
followed by immediate surgery at 1 week is an option 
treatment in rectal cancer, and it is generally accepted that 
SCRT is associated with less early toxicity than conventionally 
fractionated chemoradiotherapy. Currently, the SCRT and 
delayed surgery (i.e. 4–8 weeks) after radiotherapy (RT) is 
being evaluated in order to improve results. It seems that 
longer surgery delays are associated with a better tumor 
response, but acute toxicity has not been evaluated 
accurately. Our aim was to evaluate the acute toxicity of 
patients treated with SCRT in the weeks before the surgery in 
our hospital.  
Materials and Methods: 17 patients with localized rectal 
cancer staged T3-4N0/+ treated with 25 Gy in 5 consecutive 
fractions followed by surgery were analyzed. All patients 
received 3D conformal RT with a multileaf collimator (MLC) 
and were immobilized in the supine position. The CTV 
included the rectum, mesorectum, common and internal iliac 
vessels with a 1-cm margin, presacral space, posterior part of 
the internal obturator muscle and 1–2 cm of the bladder. 
Surgery was performed 1-3 weeks after the beginning of RT. 
Surgery was performed 1 week after RT in 6 patients, 2 
weeks after RT in 9 patients, and after 3 weeks in 2 patients. 
Acute toxicity assessment was performed during routine 
follow-up examinations and toxicity grades were assessed 
with the RTOG scale. All data analyzed by Microsoft Office 
Excel 2007. 
Results: Little toxicity was observed in the 6 patients in 
whom the surgery was performed 1 week after RT: asthenia 
(grade 1), proctitis (grade 1) and cystitis (grade 1-2). No 
other types of acute toxicity were observed. Patients in 
whom surgery was delayed 2-3 weeks after RT, acute toxicity 
get worse (≥ grade 2-3). (Figure 1)The most severe symptoms 
were asthenia, diarrhea and proctitis. Urinary incontinence 
was maintained equal. 2 patients that had surgery beyond 3 
weeks from the end of RT required admission for symptom 
control. In all cases, surgery delay was due to surgical 
waiting list. 
